Greatest increases in concern seen among Black and Hispanic adults
COVID-19 Hospitalization Tied to Higher Death Rate Than the Flu
Findings seen among those hospitalized in the VA health system during the 2022-2023 flu season
RSV Season Returns to Normal
After two years of heightened alerts, the U.S. Centers for Disease Control and Prevention (CDC) says the timing of seasonal respiratory syncytial virus (RSV) cases was disrupted during the COVID-19 pandemic.
The CDC's Morbidity and Mortality Weekly Report, published on April 7, 2023, stated RSV circulation was historically low during 2020–21.
And began earlier and continued longer during 2021–22 than previous RSV seasons.
And the 2022–23 RSV season started later than 2021–22, suggesting a return toward prepandemic seasonality.
Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
UDCA exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection
Hereditary Angioedema Remains Challenge to Diagnose, Treat
Respondents cite economic issues related to treatment, which can be compounded for patients living in rural areas
Anakinra Does Not Prevent Mechanical Ventilation in Severe COVID-19 Pneumonia
However, authors say anakinra may have a role as early treatment for patients with less severe COVID-19
More Mpox Vaccine Breakthrough Cases Confirmed
While the global outbreak of Mpox has steadily declined, recent reports indicate a resurgence of local and vaccine breakthrough cases.
For example, Public Health France reported 17 confirmed Mpox cases in the Centre-Val de Loire region in April 2023.
Pandemic Disrupted Respiratory Syncytial Virus Season Timing
However, evidence shows the 2022 to 2023 season is a return toward prepandemic seasonality
Lower Birth Weight, More Weight Gain Seen With In Utero COVID-19 Exposure
Significant proportion of the link between COVID-19 exposure and postnatal growth mediated by birth weight z-score
Rates of Irritable Bowel Syndrome Increased After COVID-19 Hospitalization
Rate of patients fulfilling criteria for depression was also higher for COVID-19 patients versus controls